CYBIN INC.
HELP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001833141
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 202611:03 AM ET | Aug 31, 2026 | Glavine PaulChief Growth Officer | PPurchaseCommon Shares | +90K | $11.5853 | +$1.04M | 4.07M | +2.3% | SEC |
| Sep 9, 20265:47 PM ET | Sep 1, 2026 | So Eric H. L.Executive Chair | PPurchaseCommon Shares | +95K | $11.805 | +$1.12M | 4.27M | +2.3% | SEC |
| Sep 10, 20266:19 AM ET | Sep 3, 2026 | Glavine PaulChief Growth Officer | PPurchaseCommon Shares | +100K | $11.7828 | +$1.18M | 4.17M | +2.5% | SEC |
| Sep 10, 20266:21 AM ET | Sep 4, 2026 | So Eric H. L.Executive Chair | PPurchaseCommon Shares | +100K | $12.089 | +$1.21M | 4.37M | +2.3% | SEC |
| Sep 11, 20269:01 AM ET | Sep 8, 2026 | So Eric H. L.Executive Chair | PPurchaseCommon Shares | +100K | $12.3867 | +$1.24M | 4.47M | +2.3% | SEC |
| Sep 11, 20269:03 AM ET | Sep 8, 2026 | Glavine PaulChief Growth Officer | PPurchaseCommon Shares | +100K | $12.4719 | +$1.25M | 4.27M | +2.4% | SEC |
| Sep 11, 20269:04 AM ET | Sep 8, 2026 | Glavine PaulChief Growth Officer | PPurchaseCommon Shares | +100K | $12.4719 | +$1.25M | 4.27M | +2.4% | SEC |
| Sep 21, 20265:07 PM ET | Sep 21, 2026 | Halstead MichaelChief Executive Officer | PPurchaseCommon Shares | +100K | $13.4705 | +$1.35M | 168.57K | +145.8% | SEC |